주식/증권
➡️ 중립
관련 뉴스
Nxera Pharma GAAP EPS of ¥15.86, revenue of ¥18.91B; reaffirms FY 2026 outlook
08/07/2026
Relmada plans NDV-01 IND by end of 2026 as cash runway extends through 2029
08/07/2026
State Bank of India reports Q1 results
08/07/2026
Here's the 1 Habit That Has Helped Ordinary Investors Build Extraordinary Wealth in the Stock Market
08/07/2026